Chk1 then phosphorylates Cdc25 on S216, and this protein kinase. These data suggest that in epithelial cells, 14-3-3 is induced in a p53-dependent manner in phosphorylation potentiates 14-3-3 (Rad24/25) binding to Cdc25. This binding prevents Cdc25 from dephosresponse to irradiation and contributes to the G2 block induced by irradiation. Binding of 14-3-3 does not inhibit phorylating Cdc2 Y15, and as a consequence, the onset of mitosis is blocked. Cdc25 S216 is phosphorylated Cdc25C phosphatase activity (Peng et al., 1997) , but because ectopically produced 14-3-3 is found in the through much of the cell cycle even in cells with undamaged DNA, suggesting that DNA damage-induced acticytoplasm, binding may act by preventing entry of Cdc25C into the nucleus, thus preventing the activation vation of Chk1 acts to maintain S216 phosphorylation in cells that have reached the end of G2 and that would of Cdc2.
Validating the Model otherwise undergo mitosis.
After irradiation of HeLa cells, Chk1 undergoes a small Much of the data outlined above indicates what might happen during operation of the DNA damage checkpoint mobility shift (Sanchez et al., 1997) like Chk1 in fission yeast, although unlike fission yeast, overproduction of control but does not yet fully establish what in fact does happen. It is now necessary to monitor the Chk1, 14-3-3, Chk1 in HeLa cells does not block mitosis. If Cdc25C S216A is produced in HeLa cells arrested in S phase, Cdc25C, and Cdc2 proteins in various mammalian cell types and to demonstrate that during the G2 delay inthen 3.8% of the cells enter mitosis. More strikingly, if cells expressing Cdc25C S216A are irradiated, within duced by irradiation, Cdc25C is phosphorylated by Chk1 and as a consequence, 14-3-3 proteins form complexes 24 hr, 60% of the cells undergo mitosis compared with only 9% of cells in a wild-type control (Peng et al., 1997) .
with Cdc25C, preventing Cdc2 activation. Mutants in these genes should be constructed to test their effects This experiment indicates that the presence of a Cdc25C tyrosine phosphatase that cannot bind 14-3-3 proteins on the checkpoint control, and efforts should be made to ensure that the 14-3-3 isoforms and Chk1 proteins compromises the DNA damage checkpoint control. The idea that the checkpoint inhibits the Cdc25C tyrosine that act in the control have been correctly identified. Finally, it is necessary to establish if ATM definitely has phosphatase is also consistent with the observed effects of irradiation on Cdc2 Y15 phosphorylation (Khara role in activating the pathway in response to DNA damage. Further work is also required in fission yeast. banda et al., 1994) .
Further support for such a model being operational The changes in the Rad3, Rad24/25, 14-3-3 proteins, and Cdc25 should be monitored after DNA damage, and in mammalian cells comes from a paper in the December issue of Molecular Cell (Hermeking et al., 1997) . Human the role of Wee1 should be clarified. Chk1 can phosphorylate Wee1 in vitro, and overproduction of Chk1 in cells colorectal carcinoma cells up-regulate the gene encoding the 14-3-3 or stratifin protein in response to irradialacking Wee1 does not cause any mitotic delay until several generations have elapsed (O'Connell et al., 1997; tion. 14-3-3 expression is found in epithelial cells but not in fibroblasts or endothelial cells. The majority of Rhind et al., 1997) , unlike wild-type cells, which respond almost immediately. These results suggest that Wee1 human cancers arise from epithelial cells, and the p53 tumor suppressor gene is genetically inactivated in may also have a role in Chk1-mediated inhibition of Cdc2. In budding yeast, the DNA damage checkpoint many of these cancers. The 14-3-3 gene contains p53 binding sites in its upstream regulatory regions, is upregdoes not operate through Y15 phosphorylation (Weinert, 1997) and so other mechanisms must be operative that ulated when p53 is overexpressed, and is not induced after irradiation when p53 is absent from cells. When may contribute to the checkpoint control in other organisms. 14-3-3 is overexpressed, cells arrest in G2 prior to mitosis, and cells lacking p21 proceed to undergo fur-
Relevance for Cancer
This model for the DNA damage checkpoint control also ther rounds of DNA replication. Both of these phenomena are explicable by 14-3-3 inhibition of the Cdc2 has implications for cancer. It is of interest that chk1 has been mapped to 11q24 (Sanchez et al., 1997) , a region that has been associated with a number of cancers. Alterations to p53 occurring during cancer progression abrogate the DNA damage checkpoint control, allowing nuclei with damaged or altered genomes to undergo mitosis, producing cells that eventually undergo apoptosis (Hermeking et al., 1997) . These differences between normal and cancer cells could account for the usefulness of radiotherapy and some types of chemotherapy for treating cancer. Modulating the behavior of components in the checkpoint pathway such as Chk1, 14-3-3, or Cdc25 could improve such therapies. For example, weakening the checkpoint control further in cancer cells or strengthening it in normal cells could be beneficial for the differential killing of cancer cells after radiotherapy. The likely conservation of these checkpoint controls means that fission yeast is a convenient model system both for the further characterization of the checkpoint pathway and for the development of relevant assays and screening procedures. These will be helpful to identify drugs and other therapeutic agents modulating the checkpoint control that could improve the treatment of cancer.
